Management of basal cell carcinoma by surveyed dermatologists in Scotland

V Gudi, Anthony Ormerod, G Dawn, C Green, R M MacKie, W S Douglas, G Gupta, Scottish Dermatological Society

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

BACKGROUND: The British Association of Dermatologists (BAD) has produced guidelines for management of basal cell carcinoma (BCC) in the UK. OBJECTIVES: Our primary objectives were to assess the management of BCCs in Scotland and to compare it with BAD guidelines. Our secondary objectives were to audit waiting times and referral patterns. METHODS: In phase I of the audit, dermatologists in 14 centres across Scotland prospectively registered demographic and clinical data of all lesions suspected to be BCCs over a 6-week period between October and December 2000. In phase II, details of management of these lesions were evaluated by case note review. RESULTS: Of the 48 consultant dermatologists contacted, 42 took part in the survey. There were 524 clinically suspected BCCs seen in 470 patients; 164 lesions in 146 patients showed pathology other than BCC and were excluded from analysis, thus leaving 360 lesions available for analysis. There was wide variation in waiting times among Scottish dermatology centres. BCCs were equally distributed between the sexes, and lesions most commonly presented in those aged 71-80 years. A diagnostic biopsy was taken in 22% of lesions, and the rest were treated definitively after a clinical diagnosis of BCC, of which 90% were confirmed on histology. Nodulocystic lesions were the most common type of tumour, comprising 48% of lesions, and most BCCs were located on the head and neck region. Correlation of the histological type of BCC and treatment received showed that nodulocystic and morpheic BCCs were managed as recommended. There were more superficial BCCs treated with surgical excision than expected (22 of 34 lesions). Four of 21 recurrent tumours and 9 of 81 tumours on high-risk areas of the face were managed with curettage and cautery or cryotherapy, rather than surgical excision. Of the 297 excised tumours, 25 (9%) were incompletely excised. All the high-risk tumours and incompletely excised tumours were offered follow-up in the dermatology clinics. CONCLUSIONS: In general, BCCs are managed according to BAD guidelines in Scotland, but waiting times vary considerably.
Original languageEnglish
Pages (from-to)648-652
Number of pages5
JournalClinical and Experimental Dermatology
Volume31
Issue number5
Early online date27 Jun 2006
DOIs
Publication statusPublished - Sep 2006

Fingerprint

Basal Cell Carcinoma
Scotland
Neoplasms
Guidelines
Dermatology
Cautery
Cryotherapy
Curettage
Consultants
Dermatologists
Histology
Neck
Referral and Consultation
Head
Demography
Pathology
Biopsy

Keywords

  • adult
  • aged
  • aged, 80 and over
  • carcinoma, basal cell
  • cohort studies
  • female
  • humans
  • male
  • middle aged
  • physician's practice patterns
  • practice guidelines as topic
  • Scotland
  • skin neoplasms
  • waiting lists

Cite this

Gudi, V., Ormerod, A., Dawn, G., Green, C., MacKie, R. M., Douglas, W. S., ... Scottish Dermatological Society (2006). Management of basal cell carcinoma by surveyed dermatologists in Scotland. Clinical and Experimental Dermatology, 31(5), 648-652. https://doi.org/10.1111/j.1365-2230.2006.02199.x

Management of basal cell carcinoma by surveyed dermatologists in Scotland. / Gudi, V; Ormerod, Anthony; Dawn, G; Green, C; MacKie, R M; Douglas, W S; Gupta, G; Scottish Dermatological Society.

In: Clinical and Experimental Dermatology, Vol. 31, No. 5, 09.2006, p. 648-652.

Research output: Contribution to journalArticle

Gudi, V, Ormerod, A, Dawn, G, Green, C, MacKie, RM, Douglas, WS, Gupta, G & Scottish Dermatological Society 2006, 'Management of basal cell carcinoma by surveyed dermatologists in Scotland' Clinical and Experimental Dermatology, vol. 31, no. 5, pp. 648-652. https://doi.org/10.1111/j.1365-2230.2006.02199.x
Gudi, V ; Ormerod, Anthony ; Dawn, G ; Green, C ; MacKie, R M ; Douglas, W S ; Gupta, G ; Scottish Dermatological Society. / Management of basal cell carcinoma by surveyed dermatologists in Scotland. In: Clinical and Experimental Dermatology. 2006 ; Vol. 31, No. 5. pp. 648-652.
@article{6914c8e8c7cc4dd885890f638b1033bc,
title = "Management of basal cell carcinoma by surveyed dermatologists in Scotland",
abstract = "BACKGROUND: The British Association of Dermatologists (BAD) has produced guidelines for management of basal cell carcinoma (BCC) in the UK. OBJECTIVES: Our primary objectives were to assess the management of BCCs in Scotland and to compare it with BAD guidelines. Our secondary objectives were to audit waiting times and referral patterns. METHODS: In phase I of the audit, dermatologists in 14 centres across Scotland prospectively registered demographic and clinical data of all lesions suspected to be BCCs over a 6-week period between October and December 2000. In phase II, details of management of these lesions were evaluated by case note review. RESULTS: Of the 48 consultant dermatologists contacted, 42 took part in the survey. There were 524 clinically suspected BCCs seen in 470 patients; 164 lesions in 146 patients showed pathology other than BCC and were excluded from analysis, thus leaving 360 lesions available for analysis. There was wide variation in waiting times among Scottish dermatology centres. BCCs were equally distributed between the sexes, and lesions most commonly presented in those aged 71-80 years. A diagnostic biopsy was taken in 22{\%} of lesions, and the rest were treated definitively after a clinical diagnosis of BCC, of which 90{\%} were confirmed on histology. Nodulocystic lesions were the most common type of tumour, comprising 48{\%} of lesions, and most BCCs were located on the head and neck region. Correlation of the histological type of BCC and treatment received showed that nodulocystic and morpheic BCCs were managed as recommended. There were more superficial BCCs treated with surgical excision than expected (22 of 34 lesions). Four of 21 recurrent tumours and 9 of 81 tumours on high-risk areas of the face were managed with curettage and cautery or cryotherapy, rather than surgical excision. Of the 297 excised tumours, 25 (9{\%}) were incompletely excised. All the high-risk tumours and incompletely excised tumours were offered follow-up in the dermatology clinics. CONCLUSIONS: In general, BCCs are managed according to BAD guidelines in Scotland, but waiting times vary considerably.",
keywords = "adult, aged, aged, 80 and over, carcinoma, basal cell, cohort studies, female, humans, male, middle aged, physician's practice patterns, practice guidelines as topic, Scotland, skin neoplasms, waiting lists",
author = "V Gudi and Anthony Ormerod and G Dawn and C Green and MacKie, {R M} and Douglas, {W S} and G Gupta and {Scottish Dermatological Society}",
year = "2006",
month = "9",
doi = "10.1111/j.1365-2230.2006.02199.x",
language = "English",
volume = "31",
pages = "648--652",
journal = "Clinical and Experimental Dermatology",
issn = "0307-6938",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Management of basal cell carcinoma by surveyed dermatologists in Scotland

AU - Gudi, V

AU - Ormerod, Anthony

AU - Dawn, G

AU - Green, C

AU - MacKie, R M

AU - Douglas, W S

AU - Gupta, G

AU - Scottish Dermatological Society

PY - 2006/9

Y1 - 2006/9

N2 - BACKGROUND: The British Association of Dermatologists (BAD) has produced guidelines for management of basal cell carcinoma (BCC) in the UK. OBJECTIVES: Our primary objectives were to assess the management of BCCs in Scotland and to compare it with BAD guidelines. Our secondary objectives were to audit waiting times and referral patterns. METHODS: In phase I of the audit, dermatologists in 14 centres across Scotland prospectively registered demographic and clinical data of all lesions suspected to be BCCs over a 6-week period between October and December 2000. In phase II, details of management of these lesions were evaluated by case note review. RESULTS: Of the 48 consultant dermatologists contacted, 42 took part in the survey. There were 524 clinically suspected BCCs seen in 470 patients; 164 lesions in 146 patients showed pathology other than BCC and were excluded from analysis, thus leaving 360 lesions available for analysis. There was wide variation in waiting times among Scottish dermatology centres. BCCs were equally distributed between the sexes, and lesions most commonly presented in those aged 71-80 years. A diagnostic biopsy was taken in 22% of lesions, and the rest were treated definitively after a clinical diagnosis of BCC, of which 90% were confirmed on histology. Nodulocystic lesions were the most common type of tumour, comprising 48% of lesions, and most BCCs were located on the head and neck region. Correlation of the histological type of BCC and treatment received showed that nodulocystic and morpheic BCCs were managed as recommended. There were more superficial BCCs treated with surgical excision than expected (22 of 34 lesions). Four of 21 recurrent tumours and 9 of 81 tumours on high-risk areas of the face were managed with curettage and cautery or cryotherapy, rather than surgical excision. Of the 297 excised tumours, 25 (9%) were incompletely excised. All the high-risk tumours and incompletely excised tumours were offered follow-up in the dermatology clinics. CONCLUSIONS: In general, BCCs are managed according to BAD guidelines in Scotland, but waiting times vary considerably.

AB - BACKGROUND: The British Association of Dermatologists (BAD) has produced guidelines for management of basal cell carcinoma (BCC) in the UK. OBJECTIVES: Our primary objectives were to assess the management of BCCs in Scotland and to compare it with BAD guidelines. Our secondary objectives were to audit waiting times and referral patterns. METHODS: In phase I of the audit, dermatologists in 14 centres across Scotland prospectively registered demographic and clinical data of all lesions suspected to be BCCs over a 6-week period between October and December 2000. In phase II, details of management of these lesions were evaluated by case note review. RESULTS: Of the 48 consultant dermatologists contacted, 42 took part in the survey. There were 524 clinically suspected BCCs seen in 470 patients; 164 lesions in 146 patients showed pathology other than BCC and were excluded from analysis, thus leaving 360 lesions available for analysis. There was wide variation in waiting times among Scottish dermatology centres. BCCs were equally distributed between the sexes, and lesions most commonly presented in those aged 71-80 years. A diagnostic biopsy was taken in 22% of lesions, and the rest were treated definitively after a clinical diagnosis of BCC, of which 90% were confirmed on histology. Nodulocystic lesions were the most common type of tumour, comprising 48% of lesions, and most BCCs were located on the head and neck region. Correlation of the histological type of BCC and treatment received showed that nodulocystic and morpheic BCCs were managed as recommended. There were more superficial BCCs treated with surgical excision than expected (22 of 34 lesions). Four of 21 recurrent tumours and 9 of 81 tumours on high-risk areas of the face were managed with curettage and cautery or cryotherapy, rather than surgical excision. Of the 297 excised tumours, 25 (9%) were incompletely excised. All the high-risk tumours and incompletely excised tumours were offered follow-up in the dermatology clinics. CONCLUSIONS: In general, BCCs are managed according to BAD guidelines in Scotland, but waiting times vary considerably.

KW - adult

KW - aged

KW - aged, 80 and over

KW - carcinoma, basal cell

KW - cohort studies

KW - female

KW - humans

KW - male

KW - middle aged

KW - physician's practice patterns

KW - practice guidelines as topic

KW - Scotland

KW - skin neoplasms

KW - waiting lists

U2 - 10.1111/j.1365-2230.2006.02199.x

DO - 10.1111/j.1365-2230.2006.02199.x

M3 - Article

VL - 31

SP - 648

EP - 652

JO - Clinical and Experimental Dermatology

JF - Clinical and Experimental Dermatology

SN - 0307-6938

IS - 5

ER -